BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $307,893 | $356,306 | $353,680 | $394,864 |
| - Cash | $114,309 | $100,710 | $119,853 | $116,436 |
| + Debt | $58,792 | $58,715 | $78,626 | $78,538 |
| Enterprise Value | $252,376 | $314,311 | $312,453 | $356,966 |
| Revenue | $43,154 | $41,092 | $41,439 | $41,020 |
| % Growth | 5% | -0.8% | 1% | – |
| Gross Profit | $36,251 | $34,727 | $37,155 | $35,199 |
| % Margin | 84% | 84.5% | 89.7% | 85.8% |
| EBITDA | $11,112 | $11,095 | $13,144 | $9,192 |
| % Margin | 25.7% | 27% | 31.7% | 22.4% |
| Net Income | $63,890 | $6,669 | $9,064 | $5,237 |
| % Margin | 148.1% | 16.2% | 21.9% | 12.8% |
| EPS Diluted | 0.61 | 0.07 | 0.09 | 0.05 |
| % Growth | 771.4% | -22.2% | 80% | – |
| Operating Cash Flow | $13,748 | $6,962 | $9,230 | $11,097 |
| Capital Expenditures | $415 | $0 | -$119 | -$296 |
| Free Cash Flow | $14,163 | $6,962 | $9,111 | $10,801 |